AMIX (STOCKS)
Autonomix Medical, Inc. Common Stock
$0.381200
+0.000900 (+0.24%)
Prev close: $0.380300
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Bradley A. Hauser
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4.39M
- Employees
- 11
- P/E (TTM)
- -0.09
- P/B (TTM)
- 0.51
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q3)
|
$-0.36 | $-0.60 | +0.2367 | +39.67% |
|
Sep 2025 (Q2)
|
$-1.38 | $-1.13 | -0.2529 | -22.44% |
|
Jun 2025 (Q1)
|
$-1.07 | $-1.00 | -0.0704 | -7.04% |
|
Mar 2025 (Q4)
|
$-1.81 | $-1.26 | -0.5503 | -43.69% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $309.00K |
| Operating Expenses | $17.55M |
| Research and Development | $7.24M |
| Other Operating Expenses | $10.31M |
| Operating Income/Loss | -$17.55M |
| Income/Loss From Continuing Operations After Tax | -$25.46M |
| Income/Loss From Continuing Operations Before Tax | -$25.46M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$25.46M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$25.46M |
| Net Income/Loss Available To Common Stockholders, Basic | -$25.46M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.15 |
| Basic Average Shares | 6,163,656 |
| Assets | $10.21M |
| Current Assets | $10.19M |
| Noncurrent Assets | $20.00K |
| Fixed Assets | $20.00K |
| Liabilities | $1.65M |
| Current Liabilities | $1.65M |
| Accounts Payable | $714.00K |
| Other Current Liabilities | $936.00K |
| Noncurrent Liabilities | $0.00 |
| Equity | $8.56M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $8.56M |
| Liabilities And Equity | $10.21M |
| Net Cash Flow From Operating Activities | -$17.65M |
| Net Cash Flow From Operating Activities, Continuing | -$17.65M |
| Net Cash Flow From Investing Activities | -$21.00K |
| Net Cash Flow From Investing Activities, Continuing | -$21.00K |
| Net Cash Flow From Financing Activities | $19.00M |
| Net Cash Flow From Financing Activities, Continuing | $19.00M |
| Net Cash Flow | $1.33M |
| Net Cash Flow, Continuing | $1.33M |
| Comprehensive Income/Loss | -$25.46M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$25.46M |
| Other Comprehensive Income/Loss | $0.00 |